ANA-positive antibodies were the most common autoantibody (68.9 %) among the SLE patients, followed by anti-dsDNA Abs (52.2 %) and ACAs (23.3 %) (Fig. 2). Here, BTG3 is linked to systemic lupus erythematosus.